CA2285631A1 - Antioxidant protein 2, gene and methods of use therefor - Google Patents

Antioxidant protein 2, gene and methods of use therefor Download PDF

Info

Publication number
CA2285631A1
CA2285631A1 CA002285631A CA2285631A CA2285631A1 CA 2285631 A1 CA2285631 A1 CA 2285631A1 CA 002285631 A CA002285631 A CA 002285631A CA 2285631 A CA2285631 A CA 2285631A CA 2285631 A1 CA2285631 A1 CA 2285631A1
Authority
CA
Canada
Prior art keywords
aop2
polypeptide
nucleic acid
seq
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002285631A
Other languages
English (en)
French (fr)
Inventor
Beverly Paigen
David R. Beier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Jackson Laboratory
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2285631A1 publication Critical patent/CA2285631A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002285631A 1997-04-02 1998-04-01 Antioxidant protein 2, gene and methods of use therefor Abandoned CA2285631A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4089797P 1997-04-02 1997-04-02
US60/040,897 1997-04-02
PCT/US1998/006666 WO1998043666A1 (en) 1997-04-02 1998-04-01 Antioxidant protein 2, gene and methods of use therefor

Publications (1)

Publication Number Publication Date
CA2285631A1 true CA2285631A1 (en) 1998-10-08

Family

ID=21913589

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002285631A Abandoned CA2285631A1 (en) 1997-04-02 1998-04-01 Antioxidant protein 2, gene and methods of use therefor

Country Status (4)

Country Link
EP (1) EP1005360A4 (de)
JP (1) JP2001522229A (de)
CA (1) CA2285631A1 (de)
WO (1) WO1998043666A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2798672B1 (fr) * 1999-09-17 2003-10-31 Commissariat Energie Atomique Formes acides des peroxyredoxines et leur utilisation comme moyen de diagnostic
AUPR221300A0 (en) * 2000-12-20 2001-01-25 Malaysian Palm Oil Board A molecular marker
WO2004043485A1 (en) * 2002-11-10 2004-05-27 Institute Of Cell Biophysics Russian Academy Of Sciences Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure
WO2012075911A1 (zh) * 2010-12-06 2012-06-14 Li Jianyuan 重组人prx-6蛋白在治疗烧烫伤和/或角膜损伤中的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06501695A (ja) * 1990-10-01 1994-02-24 ブリガム・アンド・ウイメンズ・ホスピタル 主要血管事象を抑制するためのベータ−カロテン及びビタミンｅ療法

Also Published As

Publication number Publication date
EP1005360A4 (de) 2001-02-07
JP2001522229A (ja) 2001-11-13
WO1998043666A1 (en) 1998-10-08
EP1005360A1 (de) 2000-06-07

Similar Documents

Publication Publication Date Title
US8735066B2 (en) Tumor suppressor designated TS10Q23.3
JP5202583B2 (ja) Ｔｓ１０ｑ２３．３と称する腫瘍抑制因子
CA2301199C (en) A tumor suppressor designated ts10q23.3
CA2285631A1 (en) Antioxidant protein 2, gene and methods of use therefor
US20020142417A1 (en) Antioxidant protein 2, gene and methods of use therefor
US20030078376A1 (en) Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
US6740751B2 (en) Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells
US7160720B2 (en) CHAMP—a novel cardiac helicase-like factor
WO2000034524A1 (en) Compositions and methods relating to a new cell cycle regulating gene
AU2002320547A1 (en) Champ-a cardiac helicase-like factor

Legal Events

Date Code Title Description
FZDE Dead